Pune, India, Sept. 11, 2023 (GLOBE NEWSWIRE) -- A cerebrospinal fluid leak is when the fluid surrounding your brain and spinal cord leaks out from where it’s supposed to be. If the leak is large enough, it can cause severe symptoms that make it hard or even impossible to go about your life as usual. Placement of cerebral spinal fluid (CSF) shunt systems to treat hydrocephalus is a common medical procedure and a life-saving treatment for many patients. These shunt systems drain excess fluid from the brain to another part of the body where the fluid is absorbed as part of the circulatory process. CSF shunts contain three main components: an in-flow tube (catheter), a valve that regulates the flow of fluid, and an outflow catheter that carries the fluid to the abdomen or the heart where the fluid can be absorbed.
Cerebrospinal Fluid Management Market in terms of revenue was estimated to be worth $1.91 billion in 2022 and is poised to reach $2.89 billion by 2030, growing at a CAGR of 5.3% during 2022 to 2030 according to a new report published by The Insight Partners.
The cerebrospinal fluid management market growth is propelled by increasing incidences of CSF leak and growing developments for CSF management products.
Download Sample Pages: https://www.theinsightpartners.com/sample/TIPRE00004182
Browse Comprehensive TOC on "Cerebrospinal Fluid Management Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (CSF Shunts and CSF Drainage Systems), End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Others), and Geography"
List of Tables - 112
List of Figures - 63
No. of Pages – 177
Global Cerebrospinal Fluid Management Market Scope:
| Report Coverage | Details |
| Market Size Value in | USD 1.91 Billion in 2022 |
| Market Size Value by | USD 2.89 Billion by 2030 |
| Growth rate | CAGR of 5.3% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
| Segments covered | Product, End User, and Geography |
| Regional scope | North America, Europe, Asia Pacific, Middle East & Africa, South & Central America. |
| Country scope | Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States |
| Report coverage | Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends |
Smart Cerebrospinal Fluid Shunts to Boost the Global Cerebrospinal Fluid Management Market Growth:
Shunts for hydrocephalus require an average of 10 revisions during the patient’s lifetime. The risk of diagnosis and treatment failure, limited control options, and complications have offered various opportunities for product developers. Advancements in medical technologies have allowed companies in the cerebrospinal fluid management market to introduce “smart shunts,” offering hi-tech control, diagnosis, and communication-based solutions. Smart shunts can control CSF drainage based on feedback from one or more measurement parameters inbuilt in shunt. Additionally, researchers expect that smart shunts have the potential to offer sophisticated control over mechanical operations by providing data about shunt malfunction. It is further expected to reduce the risk of shunt obstructions, eventually lowering the chances of failures. A research project named “SmartShunt – The Hydrocephalus Project” was initiated by the Institute for Dynamic Systems and Control, and the Interface Group of the Institute of Physiology at the University of Zurich to focus on shunt failure problems such as obstructions, infections, and overdrainage. The goal of the project is to develop a shunt that would function properly by using its active components and adapt to the current, evolved needs of patients.
Late-stage product development companies operating in the cerebrospinal fluid management market demand experimental results to seek approvals and commercialize smart shunts. The primary focus is on shunts designed to assess cerebrospinal fluid pressure noninvasively in physicians’ offices or at home through an implanted pressure sensor and shunts. Hence, the ongoing technological advancements are leading to significant trends such as smart shunts in the cerebrospinal fluid management market.
Global Cerebrospinal Fluid Management Market: Competitive Landscape
Medtronic plc; Integra LifeSciences Corporation; B. Braun Melsungen AG; Argi Group Health Services Ltd Sti; Sophysa SA; BeckerSmith Medical; Biometri, Spiegelberg GmbH & Co; Moller Medical GmbH, and Delta Surgical are among the leading companies operating in the cerebrospinal fluid management market. These players focus on expanding and diversifying their market presence and acquiring a novel customer base, tapping prevailing business opportunities in the cerebrospinal fluid management market.
Order a Copy of this Report at https://www.theinsightpartners.com/buy/TIPRE00004182
Global Cerebrospinal Fluid Management Market - Key Industry Dynamics:
Drivers
- Increasing Incidences of CSF Leak
- Growing Developments for CSF Management Products
Restraints
- Risk Associated with CSF Shunts
Opportunities
- Increasing Focus on Use of CSF Management for Treatment of Neurological Diseases
Trends
- Technological Developments for CSF Shunts
Recent Developments:
In September 2022, Anuncia Medical Inc received US Food and Drug Administration (FDA) approval for its ReFlow System Mini to treat patients suffering from hydrocephalus and other cerebrospinal fluid disorders that require shunting. ReFlow System Mini noninvasively facilitates a flush of ventricular catheters to restore, increase, or maintain CSF flow in a shunt.
In March 2021, the FDA granted a breakthrough device designation for the ReFlow System of Anuncia for CSF management. The device is designed to treat CSF disorders such as hydrocephalus, which require shunting. ReFlow system can be used in homecare settings and in clinics for prophylactic flushing that is performed noninvasively to potentially prevent CSF blockages.
In November 2020, Medtronic plc announced that it has completed its friendly tender offer for France-based Medicrea International, a pioneer in the transformation of spinal surgery through artificial intelligence (AI), predictive modeling, and patient specific implants. On July 15, 2020, the parties announced a friendly voluntary all-cash tender offer at the price of €7.00 per Medicrea share.
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Fluid Management Equipment Market - Global Analysis and Forecast to 2030
Fluid Management Systems Market - Global Analysis and Forecast to 2030
Standalone Fluid Management Systems Professional Market - Global Analysis and Forecast to 2030
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/cerebrospinal-fluid-management-market
